Reducing uncertainty in early oncology with patient-derived systems Integrating patient-derived xenografts and organoids can help researchers identify responsive tumor subsets, anticipate resistance, and strengthen translational confidence before clinical testing.

https://www.drugdiscoverynews.com/reducing-uncertainty-in-early-oncology-with-patient-derived-systems-16942?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz-_h7DQV_eqVMVYl-E00mCf0Ek9tHIx4e1lW-2qbGR_5Q4qo7tP47IK8DhnrTpGwA8vl5mUDnDWHrobSwy5ImK6_yNbOEA&_hsmi=401307635&utm_content=401307635&utm_source=hs_email